Be part of the knowledge.™

Project Oncology®

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.

Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

245

LikeLikedUnlike

346-360 of 360

How COVID-19 Has Changed the Way We Approach Head & Neck Cancer Care
Project Oncology®
How COVID-19 Has Changed the Way We Approach Head & Neck Cancer Care
- Jacob Sands, MD
  Peer
- Nabil F. Saba, MD, FACP
  Peer
The COVID-19 Pandemic & Dangerous Delays in Cancer Screenings
Project Oncology®
The COVID-19 Pandemic & Dangerous Delays in Cancer Screenings
- Jacob Sands, MD
  Peer
- Therese T. Bevers, MD
  Peer
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
Project Oncology®
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
- John Russell, MD
  Peer
- Richard Wender, MD
  Peer
Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer
Project Oncology®
Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer
- Brian P. McDonough, MD, FAAFP
  Peer
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Project Oncology®
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Pancreatic Cancer: The Hunt to Catch a Silent Killer
Project Oncology®
Pancreatic Cancer: The Hunt to Catch a Silent Killer
- John Russell, MD
  Peer
- Harish Lavu, MD
  Peer
advertisement
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
Project Oncology®
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
Project Oncology®
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
Linking p53 Variation to Breast Cancer Risk in African American Women
Project Oncology®
Linking p53 Variation to Breast Cancer Risk in African American Women
- Brian P. McDonough, MD, FAAFP
  Peer
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
Project Oncology®
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
Project Oncology®
Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
- Jennifer Caudle, DO, FACOFP
  Peer
- Major Kenneth Lee, IV, MD, PhD
  Peer
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
Project Oncology®
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
advertisement
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
Project Oncology®
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Project Oncology®
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
- Matt Birnholz, MD
  Peer
High Hopes for Cannabis in Oncology: Therapeutic Applications Beyond Pain Management
Clinician's Roundtable
High Hopes for Cannabis in Oncology: Therapeutic Applications Beyond Pain Management
- Matt Birnholz, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended